1. Home
  2. INKT
  3. INKT News

Latest MiNK Therapeutics Inc. (INKT) News on May 26, 2024

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting

GlobeNewswire

4 days ago

MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting

Thomson Reuters StreetEvents

2 months ago

Q4 2023 Mink Therapeutics Inc Earnings Call

Share on Social Networks: